MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study.

MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study.

The substantia nigra contains dopaminergic cells that project to the striatum and are affected by the neurodegenerative process that appears in Parkinson's disease (PD). For accurate differential diagnosis and for disease monitoring the availability of a sensitive and non-invasive biomarker for...

Descripció completa

Dades bibliogràfiques
Autors principals:	Menke, R, Scholz, J, Miller, K, Deoni, S, Jbabdi, S, Matthews, P, Zarei, M
Format:	Journal article
Idioma:	English
Publicat:	2009

Ítems similars

Connectivity-based segmentation of the substantia Nigra in human and its implications in Parkinson's disease.
per: Menke, R, et al.
Publicat: (2010)

Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease.
per: Menke, R, et al.
Publicat: (2010)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
per: Sayyed Shahid Hussain, et al.
Publicat: (2023-08-01)

Application value of multiparametric MRI for evaluating iron deposition in the substantia nigra in Parkinson's disease
per: Qing Cao, et al.
Publicat: (2023-01-01)

Substantia nigra alterations in mice modeling Parkinson’s disease
per: I. N. Rozhkova, et al.
Publicat: (2024-11-01)

Ninetieth Anniversary of Parkinson’s Disease «Substantia Nigra» Theory
per: O.N. Voskresenskaya, et al.
Publicat: (2009-06-01)

Proteome analysis of human substantia nigra in Parkinson's disease
per: Werner Cornelius J, et al.
Publicat: (2008-02-01)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
per: Helena Xicoy, et al.
Publicat: (2020-08-01)

Diagnostic value of combined assessment of olfaction and substantia nigra hyperechogenicity for Parkinson's disease
per: N. López Hernández, et al.
Publicat: (2015-10-01)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
per: T. N. Seyfried, et al.
Publicat: (2018-06-01)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
per: Paola Feraco, et al.
Publicat: (2021-06-01)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
per: Lei Liu, et al.
Publicat: (2023-09-01)

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
per: Conant Stephanie B, et al.
Publicat: (2006-10-01)

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
per: Christian Dölle, et al.
Publicat: (2016-11-01)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson’s Disease
per: Stefania Romeo, et al.
Publicat: (2014-01-01)

Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease
per: Dhairya A. Lakhani, et al.
Publicat: (2024-01-01)

Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson’s Disease Patients
per: U. Hidding, et al.
Publicat: (2017-01-01)

An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
per: Qiang Liu, et al.
Publicat: (2023-08-01)

The application value of quantitative susceptibility mapping in evaluating substantia nigra "swallow tail sign" in the diagnosis of Parkinson's disease
per: Xiao-jun GUAN, et al.
Publicat: (2018-04-01)

Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry
per: Malte Brammerloh, et al.
Publicat: (2021-10-01)

Ultrastructural localization of Porphyromonas gingivalis gingipains in the substantia nigra of Parkinson’s disease brains
per: Florian Ermini, et al.
Publicat: (2024-04-01)

Neuroprotective Effect of Ghrelin on Substantia Nigra in Parkinson Disease Model Induced -MPTP
per: Neda Nikoklam Nazif
Publicat: (2019-10-01)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
per: Hai-Yan Zhou, et al.
Publicat: (2018-07-01)

Utility of Combining Transcranial Sonography and MIBG Myocardial Scintigraphy to Evaluate Substantia Nigra in Patients with Parkinson’s Disease
per: Heisuke Mizukami, et al.
Publicat: (2024-05-01)

Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI
per: Stefan Theodor Schwarz, et al.
Publicat: (2018-01-01)

Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson's Disease
per: Lirong Jin, et al.
Publicat: (2019-02-01)

Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease
per: Zenghui Cheng, et al.
Publicat: (2020-01-01)

Stability of AI-Enabled Diagnosis of Parkinson’s Disease: A Study Targeting Substantia Nigra in Quantitative Susceptibility Mapping Imaging
per: Bin Xiao, et al.
Publicat: (2021-11-01)

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
per: Jay S Schneider
Publicat: (2018-01-01)

Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson’s Disease in Xinjiang
per: Rurui Wei, et al.
Publicat: (2023-01-01)

Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson’s disease
per: Bart de Laat, et al.
Publicat: (2024-02-01)

Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
per: Yu Yuan, et al.
Publicat: (2023-10-01)

Cognitive performance patterns in healthy individuals with substantia nigra hyperechogenicity and early Parkinson’s disease
per: Rezzak Yilmaz, et al.
Publicat: (2016-11-01)

Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia
per: Zhi-Fen Dong, et al.
Publicat: (2017-01-01)

The Effects of Enriched Environment on Substantia nigra Tissue in Parkinson’s Disease Rats with Prenatal Stress
per: Toraj Mohammad zamani, et al.
Publicat: (2019-01-01)

Anti-apoptotic effect of Shudipingchan granule in the substantia nigra of rat models of Parkinson′s disease
per: Qing Ye, et al.
Publicat: (2016-01-01)

Magnetic resonance spectroscopy imaging of medulla oblongata and substantia nigra in idiopathic Parkinson's disease
per: Netra Rana
Publicat: (2013-06-01)

Striatal Infarction Elicits Secondary Extrafocal MRI Changes in Ipsilateral Substantia Nigra.
per: Benjamin Winter, et al.
Publicat: (2015-01-01)

Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson’s disease: A 3T and 7T MRI study
per: Erind Alushaj, et al.
Publicat: (2024-01-01)

Chemical Exchange Saturation Transfer MRI Signal Loss of the Substantia Nigra as an Imaging Biomarker to Evaluate the Diagnosis and Severity of Parkinson's Disease
per: Chunmei Li, et al.
Publicat: (2017-08-01)